Literature DB >> 10825608

Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.

F P Kroon1, J T van Dissel, J C de Jong, K Zwinderman, R van Furth.   

Abstract

In a consecutive 3-year study the antibody response after immunization with influenza vaccine of a cohort of HIV-infected adults was studied. The haemagglutination-inhibiting (HAI) antibody titres after vaccination correlated with the number of CD4(+) T lymphocytes (p<0.001), the prevaccination antibody titres (p<0.001), and the proliferative response to anti-CD3 (p<0.001). Severely impaired antibody responses were observed in HIV-infected individuals with CD4(+) T-lymphocyte counts < or =100x10(6)/l. Significantly higher prevaccination antibody titres were observed in healthy controls in the 2nd or 3rd year of vaccination, but not in HIV-infected individuals. Annually repeated vaccination of HIV-infected individuals did not lead to higher postvaccination antibody titres. Annual vaccination of HIV-infected individuals with CD4(+) T-lymphocyte counts exceeding 100x10(6)/l seems to be worthwhile, although it may not be expected to render the same level of protection against influenza as in non-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825608     DOI: 10.1016/s0264-410x(00)00079-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  40 in total

1.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.

Authors:  Yuk-Fai Lau; Lay-Hoon Tang; David Chien Lye; Eng-Eong Ooi; Yee-Sin Leo
Journal:  Hum Vaccin Immunother       Date:  2017-02-17       Impact factor: 3.452

Review 3.  Factors affecting immune responses to the influenza vaccine.

Authors:  Maria R Castrucci
Journal:  Hum Vaccin Immunother       Date:  2017-07-21       Impact factor: 3.452

4.  Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.

Authors:  Shikha Garg; Prasert Thongcharoen; Prabda Praphasiri; Anupong Chitwarakorn; Pornchai Sathirapanya; Stefan Fernandez; Kamonthip Rungrojcharoenkit; Wannee Chonwattana; Philip A Mock; Wichuda Sukwicha; Jacqueline M Katz; Marc-Alain Widdowson; Marcel E Curlin; Robert V Gibbons; Timothy H Holtz; Fatimah S Dawood; Sonja J Olsen
Journal:  Clin Infect Dis       Date:  2015-10-20       Impact factor: 9.079

5.  B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.

Authors:  Saikat Boliar; Megan K Murphy; T Cameron Tran; Diane G Carnathan; Wendy S Armstrong; Guido Silvestri; Cynthia A Derdeyn
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.

Authors:  Suresh Pallikkuth; Lesley R De Armas; Rajendra Pahwa; Stefano Rinaldi; Varghese K George; Celeste M Sanchez; Li Pan; Gordon Dickinson; Allan Rodriguez; Margaret Fischl; Maria Alcaide; Savita Pahwa
Journal:  AIDS       Date:  2018-06-01       Impact factor: 4.177

7.  Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Seunghyun Won; Rachel Lee; Tahaniyat Lalani; Anuradha Ganesan; Timothy Burgess; Brian K Agan
Journal:  Vaccine       Date:  2016-08-28       Impact factor: 3.641

8.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

9.  Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

Authors:  Clarisa M Buckner; Susan Moir; Jason Ho; Wei Wang; Jacqueline G Posada; Lela Kardava; Emily K Funk; Amy K Nelson; Yuxing Li; Tae-Wook Chun; Anthony S Fauci
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.

Authors:  Robert F Pass; Sharon Nachman; Patricia M Flynn; Petronella Muresan; Terence Fenton; Coleen K Cunningham; William Borkowsky; James B McAuley; Stephen A Spector; Elizabeth Petzold; Wende Levy; George K Siberry; Ed Handelsman; L Jill Utech; Adriana Weinberg
Journal:  J Pediatric Infect Dis Soc       Date:  2013-07-17       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.